During the past decade, Tri-State Mountain Neurology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tri-State Mountain Neurology" #1 sponsor was "AbbVie" with 1 trials, followed by "American Regent, Inc." with 1 trials sponsored, "Amgen" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Tri-State Mountain Neurology" are "Multiple Sclerosis" (2 trials), "Insomnia Disorder" (1 trials), "Migraine" (1 trials) and "Restless Legs Syndrome (RLS)" (1 trials). Many other conditions were trialed in "Tri-State Mountain Neurology" in a lesser frequency.

Most popular intervention types in "Tri-State Mountain Neurology" are "Drug" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ABT-555" (1 trials), "Antihistamine" (1 trials), "Daridorexant 25 mg" (1 trials) and "Daridorexant 50 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tri-State Mountain Neurology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Tri-State Mountain Neurology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Tri-State Mountain Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tri-State Mountain Neurology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".